| Health / Medical Topics |
yttrium Y 90 epratuzumab tetraxetan
Pronunciation
A substance being studied in the treatment of certain types of B-cell cancer. Epratuzumab is a monoclonal antibody that binds to a protein called CD22, which is found on the surface of B cells. It is linked to a radioactive substance called yttrium Y 90, which may help kill cancer cells. Yttrium Y 90 epratuzumab tetraxetan is a type of radioimmunoconjugate. (NCI Dictionary)
YOU MAY ALSO LIKE
A substance being studied in the treatment of some types of cancer. Yttrium Y 90 edotreotide contains a molecule that binds to…
A substance being studied in the treatment of some types of cancer. Yttrium Y 90 DOTA-tyr3-octreotide contains a molecule that binds to…
A compound that contains the radioisotope yttrium Y 90 linked to the chemical biotin. Biotin is a molecule that binds strongly to…
A substance being studied in the treatment of advanced pancreatic cancer. Yttrium Y 90 DOTA monoclonal antibody HuPAM4 contains a monoclonal antibody…
A substance being studied in the treatment of liver cancer. HuAFP31 is a monoclonal antibody that can bind to tumor cells that…
A substance being studied in the treatment of some types of cancer. M5A is a monoclonal antibody that binds to a protein…
